CN101382540A - 血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 - Google Patents
血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 Download PDFInfo
- Publication number
- CN101382540A CN101382540A CN200810051267.8A CN200810051267A CN101382540A CN 101382540 A CN101382540 A CN 101382540A CN 200810051267 A CN200810051267 A CN 200810051267A CN 101382540 A CN101382540 A CN 101382540A
- Authority
- CN
- China
- Prior art keywords
- platelet
- antibody
- serum
- antiplatelet
- solid phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 23
- 102000036639 antigens Human genes 0.000 title claims abstract description 23
- 108091007433 antigens Proteins 0.000 title claims abstract description 23
- 108010044091 Globulins Proteins 0.000 title claims abstract description 11
- 102000006395 Globulins Human genes 0.000 title claims abstract description 11
- 239000007790 solid phase Substances 0.000 title claims abstract description 9
- 210000001772 blood platelet Anatomy 0.000 claims abstract description 71
- 238000006243 chemical reaction Methods 0.000 claims abstract description 43
- 210000002966 serum Anatomy 0.000 claims abstract description 26
- 210000004027 cell Anatomy 0.000 claims abstract description 22
- 230000000702 anti-platelet effect Effects 0.000 claims abstract description 18
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 18
- 239000013642 negative control Substances 0.000 claims abstract description 10
- 239000013641 positive control Substances 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- 230000005875 antibody response Effects 0.000 claims description 4
- 108010074605 gamma-Globulins Proteins 0.000 claims description 4
- 230000036039 immunity Effects 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 4
- 206010070834 Sensitisation Diseases 0.000 claims description 3
- 230000010100 anticoagulation Effects 0.000 claims description 3
- 238000010241 blood sampling Methods 0.000 claims description 3
- 230000008313 sensitization Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 13
- 238000001514 detection method Methods 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 15
- 238000005406 washing Methods 0.000 description 14
- 238000002156 mixing Methods 0.000 description 8
- 210000003743 erythrocyte Anatomy 0.000 description 7
- 229920000298 Cellophane Polymers 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000002274 desiccant Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810051267.8A CN101382540A (zh) | 2008-10-15 | 2008-10-15 | 血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810051267.8A CN101382540A (zh) | 2008-10-15 | 2008-10-15 | 血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101382540A true CN101382540A (zh) | 2009-03-11 |
Family
ID=40462488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810051267.8A Pending CN101382540A (zh) | 2008-10-15 | 2008-10-15 | 血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101382540A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103344755A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN106950385A (zh) * | 2017-05-23 | 2017-07-14 | 北京乐普医疗科技有限责任公司 | 一种血小板抗体检测试剂盒及其使用方法 |
CN108519483A (zh) * | 2018-05-26 | 2018-09-11 | 江苏力博医药生物技术股份有限公司 | 基于固相凝集法的血小板抗体检测试剂盒及其检测方法和应用 |
CN110082526A (zh) * | 2019-05-20 | 2019-08-02 | 中国科学院苏州生物医学工程技术研究所 | 免疫复合物的排阻层析检测新方法 |
CN110308288A (zh) * | 2019-04-16 | 2019-10-08 | 广州血液中心 | 一种新型血小板交叉配型试剂盒 |
CN112379100A (zh) * | 2020-10-13 | 2021-02-19 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN113391061A (zh) * | 2021-06-16 | 2021-09-14 | 王婷楠 | 动物免疫抗体在制备用于检测动物免疫药物中的用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1282871A (zh) * | 2000-03-29 | 2001-02-07 | 长春生物制品研究所 | 微柱凝胶法血小板血型抗原抗体检测技术和试剂盒 |
-
2008
- 2008-10-15 CN CN200810051267.8A patent/CN101382540A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1282871A (zh) * | 2000-03-29 | 2001-02-07 | 长春生物制品研究所 | 微柱凝胶法血小板血型抗原抗体检测技术和试剂盒 |
Non-Patent Citations (3)
Title |
---|
李川晟等: "简易致敏红细胞血小板血清学技术检测血小板抗体", 《中华医学检验杂志》 * |
林芳: "特异性鸡卵黄抗体(IgY)的制备及其用于去除人血浆部分高丰度蛋白的研究", 《中国优秀硕士学位论文全文数据库基础科学辑》 * |
段宝生等: "血小板抗体的固相Coomb"s试验检测试剂盒研制", 《第三次全国免疫诊断暨疫苗学术研讨会论文集》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103344755A (zh) * | 2013-07-19 | 2013-10-09 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN103344755B (zh) * | 2013-07-19 | 2015-06-24 | 中国科学院苏州生物医学工程技术研究所 | 一种磁化醛化羊红细胞的制备方法 |
CN106950385A (zh) * | 2017-05-23 | 2017-07-14 | 北京乐普医疗科技有限责任公司 | 一种血小板抗体检测试剂盒及其使用方法 |
CN108519483A (zh) * | 2018-05-26 | 2018-09-11 | 江苏力博医药生物技术股份有限公司 | 基于固相凝集法的血小板抗体检测试剂盒及其检测方法和应用 |
CN110308288A (zh) * | 2019-04-16 | 2019-10-08 | 广州血液中心 | 一种新型血小板交叉配型试剂盒 |
CN110082526A (zh) * | 2019-05-20 | 2019-08-02 | 中国科学院苏州生物医学工程技术研究所 | 免疫复合物的排阻层析检测新方法 |
CN110082526B (zh) * | 2019-05-20 | 2022-06-17 | 中国科学院苏州生物医学工程技术研究所 | 免疫复合物的排阻层析检测新方法 |
CN112379100A (zh) * | 2020-10-13 | 2021-02-19 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN112379100B (zh) * | 2020-10-13 | 2024-01-23 | 中国科学院苏州生物医学工程技术研究所 | 血小板抗人球蛋白实验免疫区带分布检测方法 |
CN113391061A (zh) * | 2021-06-16 | 2021-09-14 | 王婷楠 | 动物免疫抗体在制备用于检测动物免疫药物中的用途 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Voller et al. | Enzyme immunoassays in diagnostic medicine: theory and practice | |
CN101382540A (zh) | 血小板抗原抗体检测和交叉配型的固相抗人球蛋白试剂盒 | |
CN102798725B (zh) | 血清总IgE测定诊断试剂盒及制备和使用方法 | |
SU1496643A3 (ru) | Способ определени человеческого гемоглобина в фекали х | |
CN101196518B (zh) | 丙型肝炎病毒抗体化学发光法诊断试剂盒及其制备方法 | |
Leikola et al. | Enzyme‐linked antiglobulin test: an accurate and simple method to quantify red cell antibodies | |
CN101377504A (zh) | 一种检测弓形虫IgM抗体的化学发光免疫分析测定试剂盒 | |
CN107643409A (zh) | 一种血型抗原芯片及其在红细胞意外抗体检测中的应用 | |
CN108680756A (zh) | 一种不完全抗体检测试剂盒及检测方法 | |
US5384240A (en) | Base dissociation assay | |
CN103033611A (zh) | 致敏性变应原化学发光法诊断试剂盒及其制备方法 | |
CN1877331B (zh) | 口蹄疫病毒定型试纸条及其制备方法 | |
CN103235120A (zh) | 一种复合检测戊型肝炎病毒抗体谱的试剂盒及其应用 | |
CN102879560A (zh) | 一种精确、快速和微量检测人血清中抗原和抗体的方法 | |
CN103063841B (zh) | 一种流行性出血热病毒IgM抗体酶联免疫检测试剂盒及其制备和使用方法 | |
CN101571542A (zh) | 一种检测齐帕特罗的直接竞争法酶联免疫试剂盒 | |
CN101957365B (zh) | 检测抗环瓜氨酸肽和抗免疫球蛋白g双特异性抗体的试剂盒 | |
CN101109755A (zh) | 一种用于筛查血清中不规则抗体的试剂盒及其制备方法 | |
CN108519483A (zh) | 基于固相凝集法的血小板抗体检测试剂盒及其检测方法和应用 | |
CN101368964A (zh) | 一种检测巨细胞病毒IgG抗体的化学发光法免疫分析诊断试剂盒 | |
Fritz et al. | Hepatitis-associated antigen: detection by antibody-sensitized latex particles | |
Buakaew et al. | Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients | |
CN101368965A (zh) | 一种检测巨细胞病毒IgM抗体的化学发光法免疫分析诊断试剂盒 | |
CN107202890A (zh) | 用于轻中度脑损伤的快速诊断试剂及含有该试剂的试剂盒及该试剂盒的制备和检测方法 | |
Richard-Lenoble et al. | Human hydatidosis: evaluation of three serodiagnostic methods, the principal subclass of specific immunoglobulin and the detection of circulating immune complexes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGCHUN BLOOD BIO-TECH CO., LTD. Free format text: FORMER OWNER: LI YONG Effective date: 20110707 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 130012 NO. 433, CHENGUANG STREET, HIGH-TECH. DEVELOPMENT ZONE, CHANGCHUN CITY, JILIN PROVINCE TO: 130012 NO. 3255, QIANJIN STREET, CHANGCHUN CITY, JILIN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110707 Address after: 130012 No. 3255 Qianjin Street, Jilin, Changchun Applicant after: Changchun Brother Biotech Co., Ltd. Address before: 130012 No. 433 Chenguang street, hi tech Development Zone, Jilin, Changchun Applicant before: Li Yong |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20090311 |